Ageusia
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.
Effect of Dried Miracle Berry on the Olfactory-gustative Perception in Malnourished Cancer Patients
Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19
Smell in Covid-19 and Efficacy of Nasal Theophylline
Lactoferrin for COVID-19-Induced Taste or Smell Abnormality
Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell
Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.